会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 27. 发明申请
    • HUMAN HOMOLOGS OF THE TRANSDUCIN-LIKE ENHANCER OF SPLIT GENE AND METHODS BASED THEREON
    • 分子基因转录增强子的人类HOMOLOGY及其基于方法
    • WO1994008037A1
    • 1994-04-14
    • PCT/US1993009333
    • 1993-09-30
    • YALE UNIVERSITYMEDICAL RESEARCH COUNCILARTAVANIS-TSAKONAS, SpyridonSTIFANI, StefaniREDHEAD, Nicola, J.HILL, Robert, E.
    • YALE UNIVERSITYMEDICAL RESEARCH COUNCIL
    • C12P21/06
    • C07K14/47C07K16/18
    • The present invention relates to nucleotide sequences of the human transducin-like Enhancer of split ("TLE") genes, and amino acid sequences of their encoded TLE proteins. The invention further relates to fragments and other derivatives, and analogs, of human TLE proteins, as well as antibodies thereto. Nucleic acids encoding such fragments or derivatives are also within the scope of the invention. Production of the foregoing proteins and derivatives, e.g., by recombinant methods, is provided. Binding partners of TLE proteins are also provided. In particular, the invention provides sequences of four distinct human homologs of the Drosophila TLE gene, and sequences of their unique encoded TLE proteins. In specific embodiments, the invention relates to derivatives and analogs of the human TLE proteins which are functionally active, or which comprise one or more domains of a human TLE protein, including but not limited to the "Q domain", "GP domain", "CcN domain", "SP domain", "WD-40 domain", or a WD-40 repeat, casein kinase II (CK II) site, cdc2 kinase (cdc2) site, or nuclear localization sequence motif, consensus sequences for any of the foregoing, or any combination of the foregoing.
    • 本发明涉及分裂(“TLE”)基因的人转导素样增强子的核苷酸序列,以及它们编码的TLE蛋白的氨基酸序列。 本发明还涉及人TLE蛋白的片段和其它衍生物和类似物,以及其抗体。 编码这种片段或衍生物的核酸也在本发明的范围内。 提供了上述蛋白质和衍生物的生产,例如通过重组方法。 还提供了TLE蛋白的结合伙伴。 特别地,本发明提供了果蝇TLE基因的四个不同的人类同源物的序列,以及它们唯一编码的TLE蛋白的序列。 在具体实施方案中,本发明涉及功能上有活性或包含人TLE蛋白的一个或多个结构域的人TLE蛋白的衍生物和类似物,包括但不限于“Q域”,“GP结构域”, “CcN域”,“SP结构域”,“WD-40结构域”或WD-40重复,酪蛋白激酶II(CK II)位点,cdc2激酶(cdc2)位点或核定位序列基序, 或上述的任何组合。